Personalized Medicine News and Research

RSS

USPTO allows claims to Rosetta Genomics' two microRNA related patent applications

Rosetta Genomics today announced that the United States Patent and Trademark Office has allowed claims in two patent applications.

30 Jan 2010

New mathematical model helps in predicting treatment outcomes for cervical cancer patients

Cervical cancer is highly curable when caught early. But in a third of cases, the tumor responds poorly to therapy or recurs later, when cure is much less likely.

29 Jan 2010

Global market for oncology drugs is forecast to reach $80 billion by 2050

New Medicine's Oncology KnowledgeBASE (nm/OK) residing at http://nmok.net became available on the Internet 10 years ago and, since then, the oncology field has evolved into one of the most challenging, complex and promising drug development sectors, both in terms of its potential contribution to medicine and to its market opportunities.

29 Jan 2010

Targeted sequencing of exome can help identify potential disease-causing genes

Researchers from University of Miami Miller School of Medicine and Roche Applied Science have recently published a research study on human exome resequencing results from eight individuals that span across three generations of a family. The findings of this study showcased the value of targeted enrichment for family-based studies which allows researchers to quickly identify potential disease-causing genetic variants and will provide the data and information for further research to better understand disease and the impact across generations of a family.

29 Jan 2010

QIAGEN hosts panel discussion to educate public about the emerging promise of personalized medicine

The treatment of illness has traditionally been based on the law of averages – what works best for the largest number of patients. As a result, billions of dollars are spent every year on treatments that could be ineffective or even harmful for some patients. What if doctors could tell with a simple test which course of treatment would be best for a particular patient?

From QIAGEN Manchester Limited 29 Jan 2010

Life Technologies collaborates with Ignite Institute to create genomic sequencing center

Life Technologies Corporation and the Ignite Institute for Individualized Health announced today a collaboration to create a ground-breaking genomic sequencing center at Ignite’s new facility in Northern Virginia.

28 Jan 2010

Researchers challenge prevailing assumptions in interpreting genome-wide studies

In the decade since the Human Genome Project produced the first map of DNA sequences in the human genome, scientists throughout the world have combed through genome data to identify genes and gene variants that cause human disease.

28 Jan 2010

Top pharmaceutical companies select CRi solutions for drug research and development

Phadia's ImmunoCAP Rapid System receives FDA marketing clearance

Phadia, the world leader in allergy blood testing diagnostics, today announced that the United States Food and Drug Administration (FDA) has cleared the ImmunoCAP® Rapid Reader II, a part of the ImmunoCAP Rapid System, used to aid in the diagnosis of allergy in the physician’s office.

27 Jan 2010

Growth of OMI equipment sales to reach $400M in 2014

In vivo optical molecular imaging (OMI) is poised to move into clinical use as one of the key tools in personalized medicine, complementing more established imaging tools such as CT and MRI. Growth of equipment sales is on track to reach $400 million in 2014 and nearly $1 billion by the end of the decade.

21 Jan 2010

Ferrer inCode obtains exclusive distribution rights for ADtect test

DiaGenic ASA and Ferrer inCode today announced that they have signed a distribution agreement for the blood-based ADtect® test for early diagnosis of Alzheimer’s disease covering a total of 32 countries.

20 Jan 2010

QuantRx Biomedical's developments in genetics-based technology

QuantRx® Biomedical Corporation, a broad-based diagnostic company focused on the development and commercialization of innovative diagnostic products, today provided an update from Chairman and Chief Executive Officer Walter Witoshkin on its involvement in genetics-based personalized medicine and disease prevention.

20 Jan 2010

Affomix, City of Hope collaborate in exploring next generation sequencing using digital proteomics

Affomix Corporation, a pioneer in high performance antibody technology, announced today a collaboration with City of Hope focused on establishing the clinical utility of “digital proteomics” with next generation sequencers. One of the nation’s top cancer research and treatment centers, City of Hope is a leading provider of molecular diagnostic testing services and an innovator in clinical genetics research.

19 Jan 2010

HolGenTech PGA for Genome Based Economy to be presented at the Personalized Medicine World Conference

HolGenTech, a leader in Genome Computing Architecture, will demonstrate the world's first Personal Genome Assistant (PGA) for the Genome Based Economy at the inaugural event of the Personalized Medicine World Conference at the Mountain View Computer History Museum, January 19-20. Designed to automate best choices for consumers as they shop for food, nutrients, cosmetics and more, the HolGenTech PGA leverages data from genomic tests, health database services, and user preferences to equip consumers with a practical tool to optimize health and maximize prevention.

19 Jan 2010

AstraZeneca and Dako Denmark A/S enter into collaboration agreement

AstraZeneca and Dako Denmark A/S announced today that they have entered into a collaboration agreement to develop companion diagnostic tests for multiple AstraZeneca oncology projects, including biologics and small molecules, in various stages of discovery and development.

18 Jan 2010

Treatment for metastatic tumor based on its unique protein makeup

Imagine if treatments for disease could be based not on a patient's diagnosis but instead on the characteristics of their tissue. By identifying and decoding the cryptic messages hidden deep inside the human proteome, scientists and physicians who study personalized medicine are seeking more effective treatments and disease management for patients.

18 Jan 2010

Genomic and Personalized Medicine Conference in USA

Elsevier announced today the Genomic and Personalized Medicine Conference in Arlington, VA, USA from May 16-18, 2010, which is, supported by The Lancet and organized in association with the book 'Genomic and Personalized Medicine.

13 Jan 2010

Multigene test results impact physicians and patients' decisions on breast cancer therapy

A 21-gene test that predicts whether early stage breast cancer patients will benefit from chemotherapy is having a big impact on treatment decisions by patients and doctors alike.

12 Jan 2010

Institut Curie, Ipsogen sign scientific collaboration agreement in breast cancer domain

The INSTITUT CURIE and IPSOGEN (FR0010626028 - ALIPS) announce the signing of a scientific collaboration agreement in the breast cancer domain. Within the framework of this project, the current scientific knowledge on Ipsogen's MapQuant Dx Grade Genomic, HER2 and HR tests will be increased thanks to new data established from a large population of patients treated at the Institut Curie.

11 Jan 2010

Biomarker may enable personalized GVHD treatment for bone marrow transplant patients

University of Michigan researchers have identified the first biomarker of graft-versus-host disease of the skin. The discovery makes possible a simple blood test that should solve a treatment dilemma facing doctors with patients who frequently develop rashes after bone marrow transplants.

9 Jan 2010

Personalized Medicine News and Research

USPTO allows claims to Rosetta Genomics' two microRNA related patent applications

New mathematical model helps in predicting treatment outcomes for cervical cancer patients

Global market for oncology drugs is forecast to reach $80 billion by 2050

Targeted sequencing of exome can help identify potential disease-causing genes

QIAGEN hosts panel discussion to educate public about the emerging promise of personalized medicine

Life Technologies collaborates with Ignite Institute to create genomic sequencing center

Researchers challenge prevailing assumptions in interpreting genome-wide studies

Top pharmaceutical companies select CRi solutions for drug research and development

Phadia's ImmunoCAP Rapid System receives FDA marketing clearance

Growth of OMI equipment sales to reach $400M in 2014

Ferrer inCode obtains exclusive distribution rights for ADtect test

QuantRx Biomedical's developments in genetics-based technology

Affomix, City of Hope collaborate in exploring next generation sequencing using digital proteomics

HolGenTech PGA for Genome Based Economy to be presented at the Personalized Medicine World Conference

AstraZeneca and Dako Denmark A/S enter into collaboration agreement

Treatment for metastatic tumor based on its unique protein makeup

Genomic and Personalized Medicine Conference in USA

Multigene test results impact physicians and patients' decisions on breast cancer therapy

Institut Curie, Ipsogen sign scientific collaboration agreement in breast cancer domain

Biomarker may enable personalized GVHD treatment for bone marrow transplant patients

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News